Impact of neoadjuvant therapy in downstaging low rectal adenocarcinoma - Magri, Karina;Chia Bin, Fang
17,99 €
inkl. MwSt.

Versandfertig in 1-2 Wochen
payback
9 °P sammeln
  • Broschiertes Buch

The advent of the neoadjuvant treatment, as well as the wide acceptance of surgical concepts such as, total mesorectal excision and resection of the circumferential margin, established the management of the rectal adenocarcinoma in a whole new level of excellence. It's main benefit lies in the control of the local recurrence. Therefore, to the adequate management of rectal tumors, it's essentially that the preoperative stage should be precisely determined. The aim of this study is to evaluate the effect of the neoadjuvant therapy, in patients with rectal adenocarcinoma, on the stage (TNM); as…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
The advent of the neoadjuvant treatment, as well as the wide acceptance of surgical concepts such as, total mesorectal excision and resection of the circumferential margin, established the management of the rectal adenocarcinoma in a whole new level of excellence. It's main benefit lies in the control of the local recurrence. Therefore, to the adequate management of rectal tumors, it's essentially that the preoperative stage should be precisely determined. The aim of this study is to evaluate the effect of the neoadjuvant therapy, in patients with rectal adenocarcinoma, on the stage (TNM); as well as, authenticate the use of the magnetic resonance imaging in the loco-regional staging.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Karina Magri est professeur adjoint du département de coloproctologie de l'école médicale Santa Casa. Elle est titulaire d'un master en recherche chirurgicale de l'école de médecine Santa Casa.